#CardiometabolicDisease
What happens to fat tissue under #hypertension?
This study reveals #adipocyte dysfunction and macrophage inflammation driven by PPARγ/CBR3 activity, linking lipid accumulation to #CardiometabolicDisease. #WhiteAdiposeTissue
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
October 1, 2026 at 2:54 PM
NEW: British Bangladeshi and Pakistani populations in the UK show distinct pathways to combined mental and physical illness. A 1…

#Cardiometabolicdisease #GenesandHealthstudy #Geneticrisk #MentalHealth #Multimorbidity

#Cardiometabolicdisease #GenesandHealthstudy #Geneticrisk #MentalHealth #Mult…
South Asian Multimorbidity: Genetic and Social Risk Factors
NEW: British Bangladeshi and Pakistani populations in the UK show distinct pathways to combined mental and physical illness. A 1… #Cardiometabolicdisease #GenesandHealthstudy #Geneticrisk #MentalHealth #Multimorbidity
news.gmj.ge
September 27, 2026 at 1:26 AM
New study links rare variants in FNIP1 gene and lower body fat, less liver fat, more favourable fat distribution, and lower cardiometabolic disease. Dr Teja Rus explains in BioNews: www.progress.org.uk/rare-gene-va...
#FNIP1Gene #MetabolicHealth #CardiometabolicDisease #ExomeSequencing
August 24, 2026 at 9:01 PM
The MIRACLE Doctoral Network, an EU #MSCA-funded initiative #HorizonEurope training 12 PhDs across Europe.
We tackle #CardiometabolicDisease (heart disease, diabetes, etc.) by investigating chronic #inflammation using advanced #SingleCell tech & #AI.
April 24, 2025 at 12:23 PM
Living near an ocean polluted by #microplastics is linked to a higher #cardiometabolicdisease risk www.eurekalert.org/news-release...
July 1, 2025 at 11:02 PM
This is an important area of research in which scientists explore if and how the gut microbiome plays a role in cardiometabolic health, especially risk factors for #cardiometabolicdisease
February 12, 2025 at 7:28 PM
Starting afresh on this platform. We are a research group in the School of Medicine @universityofleeds.bsky.social our interests include #metabolism, #adipose, #muscle in a setting of #cardiometabolicdisease #diabetes #obesity #heartfailure and #exercise.
November 21, 2024 at 9:11 AM
#PaulKornerSeminar speaker @phenylauraline: "Our lab @cellbioenerglab has developed a high throughput #drugdevelopment pipeline in collaboration with researchers at @UNSW which allow us to rapidly screen new therapeutics that may reduce risk of #cardiometabolicdisease"
January 29, 2025 at 4:31 AM
#PaulKornerSeminar speaker Laura Choong @phenylauraline : "Identifying which #ceramides are beneficial or deleterious can inform the development of targeted therapeutics which can reduce #cardiometabolicdisease"
#CardioTwitter #WomeninSTEM
January 29, 2025 at 4:31 AM
#PaulKornerSeminar speaker @phenylauraline: "Our lab @cellbioenerglab has developed a high throughput #drugdevelopment pipeline in collaboration with researchers at @UNSW which allow us to rapidly screen new therapeutics that may reduce risk of #cardiometabolicdisease"
December 10, 2024 at 3:42 AM
#PaulKornerSeminar speaker Laura Choong @phenylauraline : "Identifying which #ceramides are beneficial or deleterious can inform the development of targeted therapeutics which can reduce #cardiometabolicdisease"
#CardioTwitter #WomeninSTEM
December 10, 2024 at 3:42 AM
Our latest case study shares insights from 50 Key Opinion Leaders across the US and Europe on the future of cardiometabolic disease management, including GLP-1 therapies, precision medicine, AI-driven care, and digital health.

Read:
www.sperresearch.com/Case-Studies...

#CardiometabolicDisease
June 29, 2026 at 5:36 AM
📢 Don’t miss the upcoming EASD #EarlyCareer Academy Webinar! Join Profs. Niklas Mejhert & Mikael Rydén (@ki.se) to see how high-res spatial analyses uncover adipose cell organisation & insights into health & #cardiometabolicdisease.

📅14 Oct |🕛17:00 CEST

Register 🔗👉 us06web.zoom.us/webinar/regi...
October 7, 2025 at 7:05 AM
#PaulKornerSeminar speaker @phenylauraline: "Our lab @cellbioenerglab has developed a high throughput #drugdevelopment pipeline in collaboration with researchers at @UNSW which allow us to rapidly screen new therapeutics that may reduce risk of #cardiometabolicdisease"
January 29, 2025 at 2:54 AM
#PaulKornerSeminar speaker Laura Choong @phenylauraline : "Identifying which #ceramides are beneficial or deleterious can inform the development of targeted therapeutics which can reduce #cardiometabolicdisease"
#CardioTwitter #WomeninSTEM
January 29, 2025 at 2:54 AM